The document discusses the liver's role in drug metabolism and detoxification. It outlines two main pathways - phase 1 involves activation via cytochrome P450 enzymes which can make substances more toxic, while phase 2 involves conjugation via enzymes like UDP-glucuronosyl transferase to make substances more water soluble and able to be excreted. Many dermatologic drugs can cause hepatotoxicity through idiosyncratic or intrinsic mechanisms. Ketoconazole notably carries a risk of hepatotoxicity and fulminant hepatitis. The liver's role in drug interactions is also reviewed.
This document provides an overview of extemporaneous preparations, which are medications created on-site to meet specific patient needs. It defines extemporaneous preparations and outlines their purpose. The document lists common pediatric extemporaneous preparations and provides an example of creating a frusemide suspension. It also reviews guidelines for oral liquid pediatric preparations and concludes with references. Risks of extemporaneous preparations include effects on stability, dosing errors, contamination, and acceptability. Careful formulation, documentation, and monitoring are important.
Abc analysis of given list of medication Rafi Bhat
The document analyzes medications using ABC analysis to categorize them based on their annual consumption value. It calculates the annual consumption value of each medication based on its unit cost and annual demand. It then categorizes the medications into three classes: Class A accounts for 20% of items and 53.68% of total usage, Class B accounts for 20% of items and 31.1% of usage, and Class C accounts for 60% of items but only 15.22% of usage. The analysis finds that Vitamin B Complex and Prednisolone are Class A items that require close control, while Antacid and Metformin are Class B items requiring regular review.
Systematic approach in answering DI queries requestKhadga Raj
This document outlines a systematic 7-step approach to answering drug information queries:
1. Secure demographics and contact information of the requestor.
2. Obtain relevant background information such as medical history, medications, and lab values.
3. Determine and categorize the ultimate question being asked.
4. Develop a search strategy and conduct research in primary, secondary, and tertiary literature resources.
5. Perform evaluation, analysis, and synthesis of the data found.
6. Formulate a response to the question and provide it to the requestor.
7. Conduct follow-up documentation and communication as needed.
Essential drug concept and rational use of medicinesPravin Prasad
This document discusses the essential medicine concept and rational use of medicines. It defines essential medicines as those that meet the health needs of a population based on effectiveness, safety, and cost. Essential medicine lists include generic drug names, dosage forms, strengths, and indications. Irrational medicine use can lead to ineffective or unsafe treatment, increased costs and resistance. Rational use means using medicines appropriately for each patient's needs in terms of drug choice, dosage, duration, and cost. The document outlines various educational, managerial, regulatory and economic strategies to promote rational medicine use.
Drug-induced skin reactions are common, accounting for 30% of all reported adverse drug reactions. The document discusses the epidemiology, etiology, pathophysiology, diagnosis, clinical presentations, and treatment of various drug-induced skin disorders. Mild disorders include exanthems, urticaria, fixed drug eruptions, and pruritus, while more severe disorders include erythema multiforme and erythema nodosum. Common culprit drugs are antibiotics, anticonvulsants, and NSAIDs. Treatment involves identifying and withdrawing the offending agent when possible along with symptomatic relief.
14ab1t0022 organising structure of staff, infrastructure and workload stati...Ramesh Ganpisetti
The document discusses the functions and infrastructure of a hospital pharmacy. It defines a hospital pharmacy as a department that supplies, manufactures, stores, dispenses and provides drugs and special products. It oversees the supply of medicines to patients, staff education, and developing treatment guidelines. The document recommends staffing ratios of one pharmacist per 133 patients, and outlines policies for tracking and reporting workload statistics to hospital administration to aid staff planning.
Advesre drug reaction- Types, Reporting, Evaluation, Monitoring, Preventing &...Suhas Reddy C
This document discusses adverse drug reactions (ADRs), including their definition, classification, types, reporting, evaluation, monitoring, prevention and management. It defines an ADR as an unintended reaction to a drug that occurs at normal doses. ADRs can be classified based on incidence (very common to very rare) or severity (mild to severe). Types of ADRs include dose-dependent (Type A), unpredictable hypersensitivity reactions (Type B), continuous effects of long-term drug use (Type C), and withdrawal reactions (Type E). The document outlines what information should be reported for an ADR, who is responsible for reporting, when and how to report ADRs, and where completed reports should be submitted
Drug induced hematological disorders @rxvichu!!!RxVichuZ
This is my 35th powerpoint..published here in Google Slideshare...
And I wish to thank everyone who have supported me in my 2 year long journey......
This ppt is regarding DRUG INDUCED HEMATOLOGICAL DISORDERS, covering the definitions, causative drugs, pathophysiological mechanisms, manifestations,and management of 5 blood disorders.
Do go through this ppt, and send me ur reviews!!
Regards,
Vishnu.R.Nair.
This document provides an overview of extemporaneous preparations, which are medications created on-site to meet specific patient needs. It defines extemporaneous preparations and outlines their purpose. The document lists common pediatric extemporaneous preparations and provides an example of creating a frusemide suspension. It also reviews guidelines for oral liquid pediatric preparations and concludes with references. Risks of extemporaneous preparations include effects on stability, dosing errors, contamination, and acceptability. Careful formulation, documentation, and monitoring are important.
Abc analysis of given list of medication Rafi Bhat
The document analyzes medications using ABC analysis to categorize them based on their annual consumption value. It calculates the annual consumption value of each medication based on its unit cost and annual demand. It then categorizes the medications into three classes: Class A accounts for 20% of items and 53.68% of total usage, Class B accounts for 20% of items and 31.1% of usage, and Class C accounts for 60% of items but only 15.22% of usage. The analysis finds that Vitamin B Complex and Prednisolone are Class A items that require close control, while Antacid and Metformin are Class B items requiring regular review.
Systematic approach in answering DI queries requestKhadga Raj
This document outlines a systematic 7-step approach to answering drug information queries:
1. Secure demographics and contact information of the requestor.
2. Obtain relevant background information such as medical history, medications, and lab values.
3. Determine and categorize the ultimate question being asked.
4. Develop a search strategy and conduct research in primary, secondary, and tertiary literature resources.
5. Perform evaluation, analysis, and synthesis of the data found.
6. Formulate a response to the question and provide it to the requestor.
7. Conduct follow-up documentation and communication as needed.
Essential drug concept and rational use of medicinesPravin Prasad
This document discusses the essential medicine concept and rational use of medicines. It defines essential medicines as those that meet the health needs of a population based on effectiveness, safety, and cost. Essential medicine lists include generic drug names, dosage forms, strengths, and indications. Irrational medicine use can lead to ineffective or unsafe treatment, increased costs and resistance. Rational use means using medicines appropriately for each patient's needs in terms of drug choice, dosage, duration, and cost. The document outlines various educational, managerial, regulatory and economic strategies to promote rational medicine use.
Drug-induced skin reactions are common, accounting for 30% of all reported adverse drug reactions. The document discusses the epidemiology, etiology, pathophysiology, diagnosis, clinical presentations, and treatment of various drug-induced skin disorders. Mild disorders include exanthems, urticaria, fixed drug eruptions, and pruritus, while more severe disorders include erythema multiforme and erythema nodosum. Common culprit drugs are antibiotics, anticonvulsants, and NSAIDs. Treatment involves identifying and withdrawing the offending agent when possible along with symptomatic relief.
14ab1t0022 organising structure of staff, infrastructure and workload stati...Ramesh Ganpisetti
The document discusses the functions and infrastructure of a hospital pharmacy. It defines a hospital pharmacy as a department that supplies, manufactures, stores, dispenses and provides drugs and special products. It oversees the supply of medicines to patients, staff education, and developing treatment guidelines. The document recommends staffing ratios of one pharmacist per 133 patients, and outlines policies for tracking and reporting workload statistics to hospital administration to aid staff planning.
Advesre drug reaction- Types, Reporting, Evaluation, Monitoring, Preventing &...Suhas Reddy C
This document discusses adverse drug reactions (ADRs), including their definition, classification, types, reporting, evaluation, monitoring, prevention and management. It defines an ADR as an unintended reaction to a drug that occurs at normal doses. ADRs can be classified based on incidence (very common to very rare) or severity (mild to severe). Types of ADRs include dose-dependent (Type A), unpredictable hypersensitivity reactions (Type B), continuous effects of long-term drug use (Type C), and withdrawal reactions (Type E). The document outlines what information should be reported for an ADR, who is responsible for reporting, when and how to report ADRs, and where completed reports should be submitted
Drug induced hematological disorders @rxvichu!!!RxVichuZ
This is my 35th powerpoint..published here in Google Slideshare...
And I wish to thank everyone who have supported me in my 2 year long journey......
This ppt is regarding DRUG INDUCED HEMATOLOGICAL DISORDERS, covering the definitions, causative drugs, pathophysiological mechanisms, manifestations,and management of 5 blood disorders.
Do go through this ppt, and send me ur reviews!!
Regards,
Vishnu.R.Nair.
This document discusses adverse drug reactions (ADRs), including definitions, classifications, mechanisms, and predisposing factors. It defines an ADR as an unintended, harmful reaction to a medication. ADRs are classified based on factors like type (dose-related vs unpredictable), timing (onset), and individual susceptibility. The mechanisms of different ADR types are explained in terms of pharmaceutical, pharmacokinetic, and pharmacodynamic factors. Polypharmacy, multiple diseases, age, drug properties, and genetics can predispose patients to ADRs.
This document discusses adverse drug reactions (ADRs). It defines ADRs and provides statistics on their frequency and impact. It discusses various factors that can influence ADRs, including patient characteristics like age and genetics. It also discusses drug properties and interactions that can lead to ADRs. The document classifies ADRs into types A-F based on mechanisms and timing. It provides many examples of common and serious ADRs to illustrate different types. The document emphasizes the importance of pharmacovigilance in monitoring and preventing ADRs.
Elderly patients are often defined as those over 65 years old, but aging affects individuals differently. Physiologic changes that occur with aging can impact how drugs are absorbed, distributed, metabolized, and excreted from the body. Absorption and distribution may be altered due to changes in gastrointestinal function and decreases in muscle mass. Metabolism and excretion are often decreased due to reduced liver and kidney function. These changes can affect drug efficacy, safety, and risk of interactions and adverse events. When dosing elderly patients, their multiple medical conditions, polypharmacy, and risk for non-compliance must be considered. Pharmacists can help by counseling patients and monitoring their medication therapy.
Spondylitis is a form of arthritis that affects the spine. It causes inflammation of the spinal joints that can lead to pain, discomfort, and in advanced cases, fusion of spinal sections. Spondylitis affects men more often than women. Common types include Ankylosing Spondylitis, Pott's Disease, and Spondylodiscitis. Treatment depends on the type but may include medications like NSAIDs, biologics, DMARDs, and in some cases surgery. Exercise and physical therapy can help manage symptoms.
14ab1 t0014 infection control committee and research & ethics committeeRamesh Ganpisetti
The document discusses two committees - the Infection Control Committee and the Research & Ethics Committee. The Infection Control Committee monitors infection prevention programs and policies to reduce nosocomial infections. It is composed of hospital administrators, clinicians, and cleaning staff. The Research & Ethics Committee reviews all research studies involving human participants to ensure ethical standards are followed and participants are protected. It is composed of medical, legal, and community experts. Both committees work to improve healthcare quality and safeguard patient safety through education and oversight of their respective areas.
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...MerrinJoseph1
Second Pharm D , Community Pharmacy -first chapter,definition of community pharmacy,its scope and the roles and responsibilities of community pharmacist in health care of common people,Dr.Merrin Joseph,Department of pharmacy practice
Critical evaluation of biomedical literature - clinical pharmacyShaistaSumayya
Reviewing the ‘Biomedical Literature’ poses a great challenge to the clinical professionals.
Evaluating a scientific article is a complex task.
Knowledge of the standard anatomy of an article and idiosyncrasy of various types of studies will assist the reader to review the ‘Biomedical Literature’ efficiently
Biomedical Literature includes critical appraisal of the following contents:
Title
Abstract
Introduction
Objective
Materials and Methods
Study Designs
Bias
Statistics
Results and Analysis
Discussion and Conclusion
References
Drug distribution is one of the basic service provided by the hospital pharmacy.
Drug distribution system falls in to 3 categories -
1)Ward – controlled system
2)Pharmacy controlled imprest based system
3)Pharmacy controlled patient issue system
The scope of community pharmacy includes drug information and actions, drug utilization, drug distribution, and drug selection or patient counseling. Specifically, community pharmacists provide information on pharmacology and toxicology of drugs, ensure proper stock control and drug distribution, engage in rational drug selection and counseling, and take on central responsibilities like ensuring accurate dosages, record keeping, and compliance with drug laws. They are also responsible for direct patient care like monitoring effectiveness and side effects of drugs, and educating patients through counseling on topics like medication administration and interactions.
Drug use evaluation (DUE) is a quality improvement process that reviews prescribing patterns to promote appropriate drug use. It involves identifying a drug or therapeutic area, developing criteria and standards, collecting data, evaluating results, providing feedback, and implementing interventions. The process then reevaluates drug use and revises the DUE program as needed. The presented document outlines the 11 steps of a DUE process focusing on monitoring renal function during aminoglycoside therapy.
Medication Error are the most preventable events and Clinical Pharmacists can play a vital role in preventing them. in this presentation i have tried to provide maximum information regarding medication error in minimum slides.
Extemporaneous compounding is the timely preparation of customized drug products according to a physician's prescription in order to meet individual patient needs that cannot be met by approved commercial products. It involves combining calculated amounts of ingredients into a uniform mixture. Extemporaneous compounding is used when commercial products do not have the needed dosage, strength, route of administration, or inactive ingredients are not suitable for a patient. Pharmacists must follow quality assurance procedures, label compounds properly, and ensure stability and safety.
This document summarizes the clinical pharmacokinetics of the cardiac glycoside drug digoxin. It outlines digoxin's absorption, distribution, metabolism and elimination. Absorption is around 80% orally but is affected by foods and other drugs. Distribution is extensive with a large volume of distribution that is correlated to lean body mass. Metabolism involves hepatic and renal pathways. The document then demonstrates how to determine an appropriate digoxin dose regimen for a case study patient based on pharmacokinetic parameters like volume of distribution and drug clearance. The case study calculates a loading dose and maintenance dose for the patient.
The document discusses clinical pharmacy services provided at hospitals. It focuses on ward round participation, drug therapy review, and pharmacist interventions. Key services discussed include participating in ward rounds to optimize patient treatment, monitoring drug therapy through activities like therapeutic drug monitoring and medication order review, endorsing medication charts to prevent errors, and performing clinical reviews to evaluate treatment response and safety. The pharmacist plays an important role as part of the clinical team in these activities to enhance patient outcomes.
14drugs acting on respiratory system expectorants, respiratory stimulantsGyanendra Raj Joshi
This document discusses various drugs used for treating cough and facilitating removal of respiratory secretions. It describes antitussives/cough suppressants such as codeine, dextromethorphan and noscapine which act centrally to suppress cough reflex. It also discusses expectorants like potassium iodide, ammonium chloride and bromhexine which increase production or decrease viscosity of bronchial secretions to aid in coughing up mucus. The document provides details on mechanisms of action, uses, doses and side effects of these antitussive and expectorant drugs.
This document outlines the process of drug utilization evaluation (DUE), which involves ongoing review of drug use and prescribing patterns to promote optimal drug therapy. It describes the aims of DUE as improving health outcomes, safety and costs. The DUE process involves planning studies, collecting data, evaluating results against criteria, providing feedback, developing interventions, and re-evaluating drug use. Key roles of the DUE committee and pharmacists in conducting this quality improvement process are also summarized.
This document discusses the liver's functions in detoxification and drug metabolism. It outlines the liver's two main detoxification pathways, phase 1 and phase 2 reactions, which involve oxidation and conjugation reactions to make substances more water soluble and able to be excreted. Certain dermatology drugs can cause hepatotoxicity through intrinsic or idiosyncratic mechanisms. Ketoconazole and tetracycline are highlighted as drugs that have been associated with hepatotoxicity ranging from mild elevations in liver enzymes to rare cases of fulminant hepatitis.
This document summarizes key aspects of drug metabolism and renal excretion. It discusses two phases of drug metabolism - phase I involves reactions like oxidation and phase II involves conjugation reactions. The liver is the main site of drug metabolism via cytochrome P450 enzymes in the smooth endoplasmic reticulum. Renal excretion depends on factors like a drug's polarity, glomerular filtration, and tubular secretion/reabsorption. First-pass metabolism may substantially reduce the amount of drug reaching systemic circulation following oral administration.
This document discusses adverse drug reactions (ADRs), including definitions, classifications, mechanisms, and predisposing factors. It defines an ADR as an unintended, harmful reaction to a medication. ADRs are classified based on factors like type (dose-related vs unpredictable), timing (onset), and individual susceptibility. The mechanisms of different ADR types are explained in terms of pharmaceutical, pharmacokinetic, and pharmacodynamic factors. Polypharmacy, multiple diseases, age, drug properties, and genetics can predispose patients to ADRs.
This document discusses adverse drug reactions (ADRs). It defines ADRs and provides statistics on their frequency and impact. It discusses various factors that can influence ADRs, including patient characteristics like age and genetics. It also discusses drug properties and interactions that can lead to ADRs. The document classifies ADRs into types A-F based on mechanisms and timing. It provides many examples of common and serious ADRs to illustrate different types. The document emphasizes the importance of pharmacovigilance in monitoring and preventing ADRs.
Elderly patients are often defined as those over 65 years old, but aging affects individuals differently. Physiologic changes that occur with aging can impact how drugs are absorbed, distributed, metabolized, and excreted from the body. Absorption and distribution may be altered due to changes in gastrointestinal function and decreases in muscle mass. Metabolism and excretion are often decreased due to reduced liver and kidney function. These changes can affect drug efficacy, safety, and risk of interactions and adverse events. When dosing elderly patients, their multiple medical conditions, polypharmacy, and risk for non-compliance must be considered. Pharmacists can help by counseling patients and monitoring their medication therapy.
Spondylitis is a form of arthritis that affects the spine. It causes inflammation of the spinal joints that can lead to pain, discomfort, and in advanced cases, fusion of spinal sections. Spondylitis affects men more often than women. Common types include Ankylosing Spondylitis, Pott's Disease, and Spondylodiscitis. Treatment depends on the type but may include medications like NSAIDs, biologics, DMARDs, and in some cases surgery. Exercise and physical therapy can help manage symptoms.
14ab1 t0014 infection control committee and research & ethics committeeRamesh Ganpisetti
The document discusses two committees - the Infection Control Committee and the Research & Ethics Committee. The Infection Control Committee monitors infection prevention programs and policies to reduce nosocomial infections. It is composed of hospital administrators, clinicians, and cleaning staff. The Research & Ethics Committee reviews all research studies involving human participants to ensure ethical standards are followed and participants are protected. It is composed of medical, legal, and community experts. Both committees work to improve healthcare quality and safeguard patient safety through education and oversight of their respective areas.
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...MerrinJoseph1
Second Pharm D , Community Pharmacy -first chapter,definition of community pharmacy,its scope and the roles and responsibilities of community pharmacist in health care of common people,Dr.Merrin Joseph,Department of pharmacy practice
Critical evaluation of biomedical literature - clinical pharmacyShaistaSumayya
Reviewing the ‘Biomedical Literature’ poses a great challenge to the clinical professionals.
Evaluating a scientific article is a complex task.
Knowledge of the standard anatomy of an article and idiosyncrasy of various types of studies will assist the reader to review the ‘Biomedical Literature’ efficiently
Biomedical Literature includes critical appraisal of the following contents:
Title
Abstract
Introduction
Objective
Materials and Methods
Study Designs
Bias
Statistics
Results and Analysis
Discussion and Conclusion
References
Drug distribution is one of the basic service provided by the hospital pharmacy.
Drug distribution system falls in to 3 categories -
1)Ward – controlled system
2)Pharmacy controlled imprest based system
3)Pharmacy controlled patient issue system
The scope of community pharmacy includes drug information and actions, drug utilization, drug distribution, and drug selection or patient counseling. Specifically, community pharmacists provide information on pharmacology and toxicology of drugs, ensure proper stock control and drug distribution, engage in rational drug selection and counseling, and take on central responsibilities like ensuring accurate dosages, record keeping, and compliance with drug laws. They are also responsible for direct patient care like monitoring effectiveness and side effects of drugs, and educating patients through counseling on topics like medication administration and interactions.
Drug use evaluation (DUE) is a quality improvement process that reviews prescribing patterns to promote appropriate drug use. It involves identifying a drug or therapeutic area, developing criteria and standards, collecting data, evaluating results, providing feedback, and implementing interventions. The process then reevaluates drug use and revises the DUE program as needed. The presented document outlines the 11 steps of a DUE process focusing on monitoring renal function during aminoglycoside therapy.
Medication Error are the most preventable events and Clinical Pharmacists can play a vital role in preventing them. in this presentation i have tried to provide maximum information regarding medication error in minimum slides.
Extemporaneous compounding is the timely preparation of customized drug products according to a physician's prescription in order to meet individual patient needs that cannot be met by approved commercial products. It involves combining calculated amounts of ingredients into a uniform mixture. Extemporaneous compounding is used when commercial products do not have the needed dosage, strength, route of administration, or inactive ingredients are not suitable for a patient. Pharmacists must follow quality assurance procedures, label compounds properly, and ensure stability and safety.
This document summarizes the clinical pharmacokinetics of the cardiac glycoside drug digoxin. It outlines digoxin's absorption, distribution, metabolism and elimination. Absorption is around 80% orally but is affected by foods and other drugs. Distribution is extensive with a large volume of distribution that is correlated to lean body mass. Metabolism involves hepatic and renal pathways. The document then demonstrates how to determine an appropriate digoxin dose regimen for a case study patient based on pharmacokinetic parameters like volume of distribution and drug clearance. The case study calculates a loading dose and maintenance dose for the patient.
The document discusses clinical pharmacy services provided at hospitals. It focuses on ward round participation, drug therapy review, and pharmacist interventions. Key services discussed include participating in ward rounds to optimize patient treatment, monitoring drug therapy through activities like therapeutic drug monitoring and medication order review, endorsing medication charts to prevent errors, and performing clinical reviews to evaluate treatment response and safety. The pharmacist plays an important role as part of the clinical team in these activities to enhance patient outcomes.
14drugs acting on respiratory system expectorants, respiratory stimulantsGyanendra Raj Joshi
This document discusses various drugs used for treating cough and facilitating removal of respiratory secretions. It describes antitussives/cough suppressants such as codeine, dextromethorphan and noscapine which act centrally to suppress cough reflex. It also discusses expectorants like potassium iodide, ammonium chloride and bromhexine which increase production or decrease viscosity of bronchial secretions to aid in coughing up mucus. The document provides details on mechanisms of action, uses, doses and side effects of these antitussive and expectorant drugs.
This document outlines the process of drug utilization evaluation (DUE), which involves ongoing review of drug use and prescribing patterns to promote optimal drug therapy. It describes the aims of DUE as improving health outcomes, safety and costs. The DUE process involves planning studies, collecting data, evaluating results against criteria, providing feedback, developing interventions, and re-evaluating drug use. Key roles of the DUE committee and pharmacists in conducting this quality improvement process are also summarized.
This document discusses the liver's functions in detoxification and drug metabolism. It outlines the liver's two main detoxification pathways, phase 1 and phase 2 reactions, which involve oxidation and conjugation reactions to make substances more water soluble and able to be excreted. Certain dermatology drugs can cause hepatotoxicity through intrinsic or idiosyncratic mechanisms. Ketoconazole and tetracycline are highlighted as drugs that have been associated with hepatotoxicity ranging from mild elevations in liver enzymes to rare cases of fulminant hepatitis.
This document summarizes key aspects of drug metabolism and renal excretion. It discusses two phases of drug metabolism - phase I involves reactions like oxidation and phase II involves conjugation reactions. The liver is the main site of drug metabolism via cytochrome P450 enzymes in the smooth endoplasmic reticulum. Renal excretion depends on factors like a drug's polarity, glomerular filtration, and tubular secretion/reabsorption. First-pass metabolism may substantially reduce the amount of drug reaching systemic circulation following oral administration.
Metabolism is essential for eliminating drugs and other foreign substances from the body. Phase I metabolism makes compounds more polar through reactions like oxidation and hydrolysis. Phase II metabolism further increases polarity through conjugation. The liver is the primary site of metabolism, with cytochrome P450 enzymes performing many Phase I reactions. Metabolism inactivates most compounds but can also activate prodrugs. Factors like induction, inhibition, disease, age, sex and genetics can impact an individual's drug metabolism. Proper metabolism and excretion of compounds and their metabolites terminates their biological activity.
The pharmacokinetics of many drugs are altered in patients with hepatic disease. The extent of alteration depends on the drug's elimination pathway and the severity of the liver disease. Drugs primarily metabolized by the liver will have their clearance reduced in patients with liver dysfunction. The bioavailability of drugs undergoing first-pass metabolism may increase due to reduced first-pass effect. Child-Pugh score is commonly used to assess liver disease severity and predict changes in drug pharmacokinetics. Dosage adjustments are usually required for drugs eliminated hepatically when treating patients with hepatic impairment.
A review of liver anatomy and physiology for anesthesiologistsArun Shetty
The document provides an overview of liver anatomy and physiology. It discusses the liver's macroscopic and microscopic structure, including its lobes, vascular and biliary systems. Key functions of the liver are metabolism of carbohydrates, fats, proteins, and drugs. The liver's role in hematopoiesis, bilirubin metabolism, and production of clotting factors is also summarized. Phases of drug biotransformation and factors affecting it are briefly explained. Common liver function tests and their clinical significance are reviewed to assess hepatic abnormalities.
Xenobiotics are foreign compounds that are metabolized in the body. There are two phases of xenobiotic metabolism: phase 1 involves reactions like hydroxylation that make the compound more polar, while phase 2 involves conjugating it with molecules like glucuronic acid to further increase polarity and allow excretion. Cytochrome P450 enzymes play a key role in phase 1 as they hydroxylate a wide variety of xenobiotics to make them more soluble. Understanding how the body metabolizes xenobiotics is important for fields like pharmacology, toxicology, and cancer research.
This document provides an overview of general principles of psychopharmacology. It discusses key topics including:
- Psychopharmacology is the study of how drugs affect the nervous system and behavior. Drugs can produce changes in physiological processes and behavior.
- Drugs act through various sites in the body including receptors, ion channels, enzymes, and carrier proteins. Their effects depend on how the drug structure interacts with these sites.
- Drugs are classified based on their structure, mechanism of action, history, uniqueness, and major clinical applications like antidepressants, antipsychotics, and anxiolytics.
- Pharmacodynamics examines what the body does to the drug through processes like receptors, dose
Metabolism plays an important role in drug discovery by providing information on metabolic stability, metabolic profiles, drug-drug interactions, and pharmacokinetics. Advances in fields like pharmacogenetics, pharmacogenomics, and drug transporters have expanded understanding of metabolic pathways and genetic influences. In vitro studies using liver microsomes and recombinant enzymes help identify metabolic enzymes and potential for drug interactions. Drug metabolism occurs in two phases: phase I introduces functional groups through reactions like oxidation, while phase II involves conjugating the drug with endogenous compounds like glucuronic acid to make it more soluble for excretion. Understanding metabolism aids in predicting toxicity, efficacy of drug candidates, and optimizing properties like stability.
This document provides an overview of drug metabolism. It discusses that drugs must undergo metabolism to become water soluble enough to be excreted from the body. Metabolism occurs in two phases - phase I involves reactions like oxidation and phase II involves conjugation. Key enzymes like cytochrome P450 catalyze phase I reactions in the liver. Factors like age, sex, disease state, environment, and genetic variation can impact a person's drug metabolism and influence how drugs are processed in their body. Understanding metabolism is important for predicting drug interactions and individualizing drug therapy.
Pharmacokinetics metabolism and excretionsumitmahato20
This document discusses the metabolism and excretion of drugs. It covers the following key points:
1. Drugs undergo biotransformation primarily in the liver through phase I (oxidation, reduction, hydrolysis) and phase II (conjugation) reactions to make them more polar and excretable.
2. The metabolites can be inactive, active, or activate prodrugs. Enzyme inhibition and induction can impact drug metabolism.
3. Excretion occurs mainly through the kidneys and liver into urine and bile. Lungs, saliva, sweat and milk are minor excretion routes.
4. The plasma half-life determines the dosing frequency needed to maintain therapeutic drug levels. D
This document summarizes various inborn errors of metabolism, including:
- Disorders of amino acid metabolism such as phenylketonuria (PKU), tyrosinemia, maple syrup urine disease (MSUD), homocystinuria, and nonketotic hyperglycinemia.
- Urea cycle defects which result in abnormal nitrogen metabolism and elevated ammonia levels.
- Disorders of organic acid metabolism including propionic acidemia, methylmalonic acidemia, isovaleric acidemia, and glutaric aciduria type 1.
- A disorder of fatty acid metabolism, medium-chain acyl-CoA dehydrogenase deficiency (MCAD), is also mentioned.
CHRONOPHARMACOKINETICS AND TIME DEPENDENT PHARMACOKINETICSN Anusha
Chronopharmacokinetic studies have been demonstrating that time of administration is a possible factor of variation in the kinetics of the drug.
It entails the study of temporal changes in drug absorption, distribution, metabolism and elimination.
It investigates the variation in drug plasma levels as a function of time of day and the mechanisms responsible for time dependant variations.
The term circadian coined by Franz Halberg, comes from Latin.
“Circa” means around &“diem” means day.
Drug induced liver injury- pathophysiology and causes.pptxjyoti verma
Liver injury is a possible consequence of
ingestion of any xenobiotic, including industrial toxins, pharmacologic agents, and
complementary and alternative medications (CAMs).
Among patients with acute liver failure, drug-induced liver injury (DILI) is the most common cause.
This document discusses drug metabolism. It defines drug metabolism as the chemical reactions that occur in the body to convert drugs into water-soluble compounds that can be easily excreted from the body. The main organs involved in drug metabolism are the liver, kidneys, lungs, intestine, skin, and brain. There are two phases of drug metabolism - phase I involves reactions like oxidation, reduction, and hydrolysis that make the drug more polar. Phase II involves conjugation reactions like glucuronidation and acetylation that make the drug even more hydrophilic to facilitate excretion. Factors like genetic variations, diseases, age, and gender can affect an individual's drug metabolism.
Drug metabolism involves the biochemical modification of pharmaceutical substances by living organisms through specialized enzyme activity. There are four main stages: absorption, distribution, metabolism, and elimination. Drugs are metabolized to make them more hydrophilic so they can be excreted from the body. The two main phases of drug metabolism are phase I, which introduces functional groups to drugs through reactions like oxidation, and phase II, which involves conjugating drugs to make them more polar and excretable through conjugation reactions. Cytochrome P450 enzymes are largely responsible for phase I reactions. Factors like genetics, age, sex, disease states, and environmental exposures can impact an individual's drug metabolism capacity and response.
Drug use in hepatic and renal impairmentAkshil Mehta
- Drugs are more likely to accumulate and cause toxicity in patients with impaired liver or kidney function due to reduced drug metabolism and excretion. The pharmacokinetics of many drugs are altered in patients with hepatic or renal impairment.
- In liver disease, drug absorption, metabolism, protein binding, and elimination can all be affected. Dosage reductions are often required for drugs that are metabolized by the liver. Hepatotoxic drugs should be avoided when possible.
- In kidney disease, drug absorption and excretion may be altered. Drugs that are weak acids or bases can be "trapped" in the urine through changes in urine pH. Dosage adjustments are often needed for drugs excreted by
This document provides an overview of pharmacokinetics concepts including absorption, distribution, metabolism, and excretion of drugs in the body. It defines key pharmacokinetic parameters such as volume of distribution, clearance, and half-life that influence drug dosing. Factors that can affect these parameters like protein binding, drug properties, metabolism pathways like the cytochrome P450 system, and drug interactions are summarized. The role of pharmacogenetics in drug metabolism and an example involving CYP2C19 and clopidogrel metabolism are highlighted.
Hepatic failure and hepatorenal syndrome are characterized by liver dysfunction and associated kidney impairment. Portal hypertension and toxins that normally metabolized by the liver can accumulate in the brain, causing encephalopathy. Hepatorenal syndrome is classified as type 1 with rapid renal decline or type 2 with slower progression. It involves circulatory changes and activation of vasoactive systems. Treatment focuses on correcting precipitating factors, volume expansion, medications to constrict renal vasculature, and liver transplantation which is the definitive treatment. Dialysis may be used as a bridge to transplantation.
Microsomal enzymes like cytochrome P450 and UDP glucoronosyl transferases are important for drug metabolism in the liver and other tissues. Cytochrome P450 enzymes catalyze oxidation, reduction, and other phase I reactions. UDP glucoronosyl transferases catalyze phase II conjugation reactions like glucoronidation. Drug metabolism can be induced or inhibited by other drugs and environmental factors, leading to potential drug-drug interactions. A better understanding of an individual's genetic polymorphisms and environmental factors can help optimize drug therapy and avoid adverse reactions.
Similar to Hepatic effects of dermatological drugs (20)
This document discusses using video capsule endoscopy (VCE) to diagnose and monitor Crohn's disease and investigate obscure gastrointestinal bleeding. It also mentions using confocal laser endomicroscopy to examine the small bowel. The presentation concludes by thanking the audience.
This document discusses the causes and management of upper gastrointestinal bleeding. It begins by listing common causes such as portal hypertension, peptic ulcer disease, angiomatous malformations, and neoplasms. For portal hypertension, it focuses on variceal bleeding and techniques for controlling acute variceal hemorrhage such as band ligation, sclerotherapy, and cyanoacrylate injection. For peptic ulcer disease, it covers risk assessment using the Forrest classification and Rockall score, medical and endoscopic treatment options, and the role of H. pylori eradication. It also briefly discusses less common causes of upper GI bleeding like Dieulafoy lesions and telangectasia.
This document discusses metabolic endoscopy and intragastric balloons as a treatment option for obesity. It notes that obesity requires a multidisciplinary approach, and that treatment options include pharmaceutical, interventional, and surgical approaches as well as lifestyle modifications involving nutrition education, psychological support, and medical treatment. Specifically, it focuses on intragastric balloons as an interventional endoscopic technique for obesity treatment, how the balloons work, and their removal process.
Early Detection and Management of Oesophageal and Gastric TumoursHossam Ghoneim
Early Detection and Management of Oesophageal and Gastric Tumours
This document outlines techniques for early detection and management of oesophageal and gastric tumours. It discusses various imaging techniques like chromoendoscopy, magnification endoscopy, narrow-band imaging and autofluorescence imaging that can help differentiate lesions. Early detection is important for conditions like Barrett's esophagus and early gastric cancer. Management options discussed include endoscopic mucosal resection and endoscopic submucosal dissection, with ESD providing better en bloc resection rates but being more complex. The document provides an overview of current guidelines and research findings on classifying, detecting and treating premalignant and malignant conditions of the upper GI tract.
This document discusses obesity and various treatment options. It defines BMI ranges for normal weight, overweight, obese, and morbidly obese. Treatment options include surgical procedures like gastric bypass and banding, as well as non-surgical options like weight loss programs, pharmaceutical agents, and intragastric balloons. New treatment developments discussed include the intragastric BIB balloon system, newer pharmaceuticals like Contrave and Liraglutide, endoscopic procedures like Endobarrier, and the laparoscopic MAESTRO V-bloc neuroblocking system. The document emphasizes a team-based approach and lists criteria for success and complications of different treatments.
This document discusses colorectal polyps and carcinomas, including definitions, classifications, diagnoses, and characterizations. It describes the pathological classifications of neoplastic and non-neoplastic polyps. Neoplastic polyps include adenomas, carcinomas, and submucosal tumors. Adenomas can be characterized by their histopathology, endoscopic appearance, and associations with polyposis syndromes. Serrated adenomas and familial adenomatous polyposis are also summarized. The document outlines hereditary non-polypoid colorectal cancer and submucosal tumors of the colon.
This document discusses obscure gastrointestinal bleeding (OGIB), which constitutes about 5% of GI bleeding cases and can have significant morbidity and mortality. OGIB is bleeding of unknown origin after an initial negative endoscopic evaluation. It may present as recurrent iron deficiency anemia, fecal occult blood tests, melena, or hematochezia. Evaluation tools include video capsule endoscopy (VCE), push enteroscopy, double balloon enteroscopy, single balloon enteroscopy, intra-operative enteroscopy, and imaging. VCE has a high sensitivity of 89-92% and specificity of 95% for detecting small bowel lesions that may have been missed on previous endoscopies. Common VCE findings in cases of OGIB
A 19-year-old female presented with dysphagia and odynophagia for a few days without weight loss or other symptoms. Examination found normal vital signs and no other abnormalities. Endoscopy initially showed an upper esophageal lesion of unclear etiology. Narrow band imaging revealed the lesion to be inflammatory and ulcerative rather than cancerous. Further history revealed the patient was taking tetracycline with only sips of water while lying down, confirming the diagnosis of pill esophagitis. No local endotherapy was needed at this time unless a benign stricture develops.
This document discusses four clinical cases involving gallstones and bile duct issues.
Case 1 involves a 40-year-old woman with acute gallstone pancreatitis who underwent medical treatment and may require surgery if symptoms recur. Case 2 is a 53-year-old woman with vague upper abdominal symptoms who was managed medically with follow up. Case 3 is a 67-year-old woman with jaundice, weight loss, and elevated tumor marker found to have a hilar mass requiring further investigation and management. Case 4 is a 41-year-old woman with acute gallstone pancreatitis and CBD stones seen on ultrasound who requires further evaluation and treatment.
Celiac disease is a chronic autoimmune disorder caused by an inability to tolerate gluten, which is found in wheat, rye, and barley. It affects around 1% of the global population and is diagnosed through blood tests, genetic testing, and confirmation via small intestine biopsy showing villous atrophy. The only treatment is strict, lifelong adherence to a gluten-free diet. Left untreated, it can lead to malnutrition and various complications.
Closing the Gab between Blue Ocean Strategy and Execution by W.Chan Kim and R...Hossam Ghoneim
The document provides an overview of blue ocean strategy (BOS). It defines BOS as creating a market without competition by innovating in a way that makes existing competitors irrelevant. It discusses how to formulate a BOS through tools like reconstructing market boundaries and focusing on value innovation over competition. It also emphasizes the importance of execution, noting keys like overcoming organizational hurdles, building execution into the strategy, and maintaining sustainability. The document uses the example of Comic Relief, a UK charity, to illustrate how aligning the value, people, and profit propositions can create differentiation and low costs to achieve a successful BOS.
This document presents a case study of a 31-year-old female patient complaining of worsening heartburn impairing her quality of life for the past year. A trial of PPI therapy provided marked improvement in her symptoms. Two months later, her symptoms recurred, and an endoscopy showed a small hiatal hernia with no signs of reflux and positive H. pylori infection. Ambulatory pH monitoring showed pathological acid reflux. She was treated for H. pylori and maintained on PPI therapy, but complained of increased nocturnal heartburn on step-down therapy. The document discusses various treatment approaches and indications for surgery.
NAFLD is a disease caused by obesity and epigenetic factors such as having an obese mother or not being breastfed. The disease begins with excess fat building up in the liver due to obesity which can then progress to inflammation and damage of the liver cells if not addressed. The pathogenesis involves genetic and environmental factors that influence how the body processes and stores fat in the liver.
This document provides an overview of liver disease, including the anatomy and blood flow of the liver, histology, cirrhosis, and complications of liver disease such as portal hypertension, ascites, and hepatocellular carcinoma. It also discusses the evaluation and scoring of liver disease severity, as well as nutrition recommendations for patients with liver disease. Key points covered include maintaining adequate protein intake while limiting salt and, in some cases, fat and carbs depending on the stage of liver disease.
The document discusses the history and use of intragastric balloons for weight loss. It provides details on early balloon models from the 1980s that had problems, as well as criteria developed in 1987 for effective balloons. The BIB system balloon is described as round, smooth, and saline-filled to avoid issues of earlier models. Experience with over 400 patients in Egypt is summarized, finding weight loss of 15-25kg on average with few complications and high success rates. Contraindications and ideal candidates for the procedure are also outlined.
This document provides an overview of the immunology of parasitic diseases. It discusses the immune system and its response to parasitic infections, including the roles of innate immunity, acquired immunity, T helper cells, macrophages, B cells, and antibodies. It also covers immunopathogenesis, immunodiagnosis, and approaches to immunization against parasitic diseases.
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder characterized by abdominal pain and altered bowel habits without any organic cause. It affects 3-22% of the population worldwide. While the exact cause is unclear, it is believed to involve altered gut motility, hypersensitivity, and psychosocial factors. Diagnosis is made based on symptoms according to the Rome criteria and excludes other conditions. Treatment involves dietary modifications, medications to target predominant symptoms such as fiber for constipation or alosetron for diarrhea, and treatment of accompanying psychiatric conditions like anxiety or depression.
This document provides an overview of inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease. Some key points:
- IBD is a group of chronic inflammatory disorders of the gastrointestinal tract of unknown cause. UC primarily involves the colonic mucosa, while Crohn's can involve all layers of the intestinal wall.
- Treatment involves medications to control inflammation like aminosalicylates, corticosteroids, immunosuppressants, antibiotics, and antispasmodics. Surgery is reserved for complications.
- UC has a 20-25% risk of requiring colectomy. Prognosis is variable but long-term mortality is around 5
1) Hepatitis C infection rates vary widely across regions in Egypt, ranging from 5.9% in Alexandria to 28.4% in Lower Egypt.
2) Guidelines for diagnosing and treating Hepatitis C infection in Egypt involve testing for HCV antibodies and PCR, conducting clinical exams and liver tests, and considering factors like comorbidities and disease stage to determine treatment approach.
3) Treatment options have expanded in recent years to include all-oral regimens without interferon of varying durations, from one month to a year, improving outcomes and simplifying treatment.
At Malayali Kerala Spa Ajman we providing the top quality massage services for our customers.
Our massage center prioritizes efficiency to ensure a quality massage experience for our clients at Malayali Kerala Spa Ajman. We offer a convenient appointment system and precise massage services.
Reach us at Villa No 7, Near Ammar Bin Yasir Street Al Rashidiya 2 - Ajman - United Arab Emirates.
Phone : +971 529818279
Health Tech Market Intelligence Prelim Questions -Gokul Rangarajan
The Ultimate Guide to Setting up Market Research in Health Tech part -1
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
This lays foundation of scoping research project what are the
Before embarking on a research project, especially one aimed at scoping and defining parameters like the one described for health tech IT, several crucial considerations should be addressed. Here’s a comprehensive guide covering key aspects to ensure a well-structured and successful research initiative:
1. Define Research Objectives and Scope
Clear Objectives: Define specific goals such as understanding market needs, identifying new opportunities, assessing risks, or refining pricing strategies.
Scope Definition: Clearly outline the boundaries of the research in terms of geographical focus, target demographics (e.g., age, socio-economic status), and industry sectors (e.g., healthcare IT).
3. Review Existing Literature and Resources
Literature Review: Conduct a thorough review of existing research, market reports, and relevant literature to build foundational knowledge.
Gap Analysis: Identify gaps in existing knowledge or areas where further exploration is needed.
4. Select Research Methodology and Tools
Methodological Approach: Choose appropriate research methods such as surveys, interviews, focus groups, or data analytics.
Tools and Resources: Select tools like Google Forms for surveys, analytics platforms (e.g., SimilarWeb, Statista), and expert consultations.
5. Ethical Considerations and Compliance
Ethical Approval: Ensure compliance with ethical guidelines for research involving human subjects.
Data Privacy: Implement measures to protect participant confidentiality and adhere to data protection regulations (e.g., GDPR, HIPAA).
6. Budget and Resource Allocation
Resource Planning: Allocate resources including time, budget, and personnel required for each phase of the research.
Contingency Planning: Anticipate and plan for unforeseen challenges or adjustments to the research plan.
7. Develop Research Instruments
Survey Design: Create well-structured surveys using tools like Google Forms to gather quantitative data.
Interview and Focus Group Guides: Prepare detailed scripts and discussion points for qualitative data collection.
8. Sampling Strategy
Sampling Design: Define the sampling frame, size, and method (e.g., random sampling, stratified sampling) to ensure representation of target demographics.
Participant Recruitment: Plan recruitment strategies to reach and engage the intended participant groups effectively.
9. Data Collection and Analysis Plan
Data Collection: Implement methods for data gathering, ensuring consistency and validity.
Analysis Techniques: Decide on analytical approaches (e.g., statistical
Test bank advanced health assessment and differential diagnosis essentials fo...rightmanforbloodline
Test bank advanced health assessment and differential diagnosis essentials for clinical practice 1st edition myrick.
Test bank advanced health assessment and differential diagnosis essentials for clinical practice 1st edition myrick.
Test bank advanced health assessment and differential diagnosis essentials for clinical practice 1st edition myrick.
About CentiUP - Product Information Slide.pdfCentiUP
A heightened child formula, with the trio of Nano Calcium, HMO, and DHA mixed in the golden ratio, combined with NANO technology to help nourish the body deeply and comprehensively, helps children increase height, boost brain power, and improve the immune system and overall well-being.
English Drug and Alcohol Commissioners June 2024.pptxMatSouthwell1
Presentation made by Mat Southwell to the Harm Reduction Working Group of the English Drug and Alcohol Commissioners. Discuss stimulants, OAMT, NSP coverage and community-led approach to DCRs. Focussing on active drug user perspectives and interests
Test bank clinical nursing skills a concept based approach 4e pearson educati...rightmanforbloodline
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVedanta A
Air Ambulance Services In Rewa works in close coordination with ground-based emergency services, including local Emergency Medical Services, fire departments, and law enforcement agencies.
More@: https://tinyurl.com/2shrryhx
More@: https://tinyurl.com/5n8h3wp8
Malayali Kerala Spa in Ajman, one among the top rated massage centre in ajman, welcomes you to experience high quality massage services from massage staffs from all ove rthe world! Being the best spa massage service providers, we take pride in offering traditional massage services of different countries, like
Indian Massage, Kerala Massage, Thai Massage, Pakistani Massage, Russian Massage etc
If you are seeking relaxation, pain relief, or wellness experience, our ajman spa is here for your unique needs and concerns. The services of our experienced therapists, and personalized attention will ensure that each visit will be memorable for you.
Book your appointment today and let us take you to a world of serenity and self-care. Because you deserves the best.
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...DrDevTaneja1
Digital India will need a big trained army of Health Informatics educated & trained manpower in India.
Presently, generalist IT manpower does most of the work in the healthcare industry in India. Academic Health Informatics education is not readily available at school & health university level or IT education institutions in India.
We look into the evolution of health informatics and its applications in the healthcare industry.
HIMMS TIGER resources are available to assist Health Informatics education.
Indian Health universities, IT Education institutions, and the healthcare industry must proactively collaborate to start health informatics courses on a big scale. An advocacy push from various stakeholders is also needed for this goal.
Health informatics has huge employment potential and provides a big business opportunity for the healthcare industry. A big pool of trained health informatics manpower can lead to product & service innovations on a global scale in India.
The Ultimate Guide in Setting Up Market Research System in Health-TechGokul Rangarajan
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
"Market Research it too text-booky, I am in the market for a decade, I am living research book" this is what the founder I met on the event claimed, few of my colleagues rolled their eyes. Its true that one cannot over look the real life experience, but one cannot out beat structured gold mine of market research.
Many 0 to 1 startup founders often overlook market research, but this critical step can make or break a venture, especially in health tech.
But Why do they skip it?
Limited resources—time, money, and manpower—are common culprits.
"In fact, a survey by CB Insights found that 42% of startups fail due to no market need, which is like building a spaceship to Mars only to realise you forgot the fuel."
Sudharsan Srinivasan
Operational Partner Pitchworks VC Studio
Overconfidence in their product’s success leads founders to assume it will naturally find its market, especially in health tech where patient needs, entire system issues and regulatory requirements are as complex as trying to perform brain surgery with a butter knife. Additionally, the pressure to launch quickly and the belief in their own intuition further contribute to this oversight. Yet, thorough market research in health tech could be the key to transforming a startup's vision into a life-saving reality, instead of a medical mishap waiting to happen.
Example of Market Research working
Innovaccer, founded by Abhinav Shashank in 2014, focuses on improving healthcare delivery through data-driven insights and interoperability solutions. Before launching their platform, Innovaccer conducted extensive market research to understand the challenges faced by healthcare organizations and the potential for innovation in healthcare IT.
Identifying Pain Points: Innovaccer surveyed healthcare providers to understand their difficulties with data integration, care coordination, and patient engagement. They found widespread frustration with siloed systems and inefficient workflows.
Competitive Analysis: Analyzed competitors offering similar solutions in healthcare analytics and interoperability. Identified gaps in comprehensive data aggregation, real-time analytics, and actionable insights.
Regulatory Compliance: Ensured their platform complied with HIPAA and other healthcare data privacy regulations. This compliance was crucial to gaining trust from healthcare providers wary of data security issues.
Customer Validation: Conducted pilot programs with several healthcare organizations to validate the platform's effectiveness in improving care outcomes and operational efficiency. Gathered feedback to refine features and user interface.
2. OutlineOutline
• Background
§ Liver functions
§ Detoxification pathways in the liver
§ Pharmacologic implications of hepatic metabolism
§ Role of hepatic metabolism in drug interactions
• Drug induced hepatotoxicity
§ Overview
§ Factors influencing susceptibility
§ Pathophysiologic mechanisms
§ Clinicopathological patterns
• Dermatology drugs & the liver
• Diagnosis of Hepatotoxicity
• Treatment of Hepatotoxicity
3. Liver FunctionsLiver Functions
• Metabolic (homeostasis, regulating energy balance)
§ Carbohydrate metabolism
§ Fat metabolism
§ Protein metabolism
• Synthetic
§ E.g. Albumin and Prothrombin
• Detoxification
§ Drugs
§ Toxins
§ Products of metabolism (e.g. urea & ammonia)
4. Liver Detoxification PathwaysLiver Detoxification Pathways
• Inside the liver cells there are sophisticated
mechanisms to break down toxic substances.
• Every drug, artificial chemical, pesticide and
hormone, is broken down (metabolized) by enzyme
pathways inside the liver cells.
• Many of the toxic chemicals that enter the body are
only fat-soluble.
• This makes them difficult for the body to excrete.
5. The Liver Detoxification PathwaysThe Liver Detoxification Pathways
• Fat soluble chemicals have a high affinity for fat tissues
and cell membranes, which are made of fatty substances.
• In these fatty parts of the body, toxins may be stored for
years, being excreted during times of exercise & fasting.
• During release of these toxins, symptoms like headache,
poor memory, nausea, fatigue & dizziness may occur.
• The liver has two mechanisms designed to convert fat-
soluble chemicals into water soluble chemicals
facilitating easy excretion from the body via watery fluids
such as bile and urine.
6. How does the Liver DetoxifyHow does the Liver Detoxify
Harmful Substances?Harmful Substances?
7. First Pass MechanismFirst Pass Mechanism
• Phase 1 reactions
§ Mainly for activation (yielding active intermediate metabolites)
§ Cytochrome P-450 mediated (many isoenzymatic substrates)
§ Primarily oxidative in nature (i.e. maybe in itself toxic)
§ Products of this step usually undergo further
metabolism via phase 2 reactions
§ Thus phase 1 may be regarded as potential
“toxification” while phase 2 as “detoxification”.
8. First Pass MechanismFirst Pass Mechanism
(note about CYP(note about CYP--450)450)
§ CYP450s are mainly in hepatocytes, but also cells of the kidney, lung,
intestine, skin, testis, brain
§ Each CYP450 oxidises many substrates (with some selectivity)
§ nomenclature of CYP450s:
• Example P4502E1
§ first number (i.e. "2") refers to CYP family (>40% homology)
§ capital letter (i.e. "E") refers to subfamilies (>60% homology)
§ second number (i.e. "1") refers to a particular P450 isoform
§ major human cytochrome P450s (also called hepatic mono-oxygenases)
• Example CYP1A2
§ is expressed universally in liver tissue
§ metabolises drugs such as: caffeine, theophylline, phenacetin by dealkylations
§ also activates aromatic amino procarcinomages
9. Second Pass mechanismSecond Pass mechanism
• Phase 2 reactions
§ Mainly conjugation, converting active metabolite to non
toxic more hydrophilic products to be excreted through bile
or kidney
• glucuronidation - transfer of glucuronic acid to drug
§ enzyme involved: UDP-glucuronosyl transferase
§ cofactor required: UDP-glucuronic acid
• sulphation - transfer SO3- to drug
§ enzyme involved: sulfotransferase
§ cofactor required: PAP-sulphate
• acetylation (transfer of acetyl group to drug)
§ enzymes involved: N-acetyltransferase
§ cofactor required: acetyl CoA
• glutathione conjugation (add glutathione to drug)
§ enzyme involved: glutathione-S-transferase
§ cofactor required: glutathione
10. Pharmacological implications of drugPharmacological implications of drug
metabolismmetabolism
• Modification by phase I and phase II reactions usually
alters the pharmacological properties of the agent
§ pharmacological deactivation
• most drug metabolites exhibit less affinity for relevant receptors,
thus biotransformation usually implies pharmacological deactivation
• biotransformation also typically generates metabolites that are more
easily cleared from the body, further diminishing the duration of a
drug's action
§ pharmacological activation
• for a few drugs, inactive prodrugs undergo metabolism within the
body to active drugs
11. Role of hepatic metabolism in drugRole of hepatic metabolism in drug
interactionsinteractions
• knowing the metabolic fate of drug is important
§ It can help avoid adverse effects due to drug interactions during
treatment with 2 or more drugs
• example: ketoconazole is metabolised by a specific CYP450 (3A4) and can
inhibit the clearance of terfenadine which is a substrate for the same
CYP450 (hence cardiac toxicity) “Torsade de point”
§ Prolonged exposure to some drugs can cause over expression of
CYP450s (induction) causing a loss of potency of other drugs that are
metabolized via that isoform
• example: barbiturates induce specific CYP, and ethinylestradiol
(contraceptive) is metabolised by this CYP, and so is metabolised too
quickly (therefore ineffective) if patient is taking barbiturates
12. DrugDrug--induced hepatotoxicityinduced hepatotoxicity
OverviewOverview
• Accounts for
§ 2-5% of all cases of Jaundice in hospitalized patients
§ 40% of hepatitis cases over 50yrs
§ 25% of cases of fulminant hepatitis
• Spectrum of disease ranges from subclinical to
subfulminant or even fulminant hepatitis requiring
liver transplantation.
• It can mimic any type of liver disease.
• Early recognition is essential since morbidity is
greatly increased if the drug is continued.
• OTC medications & herbal remedies may have
profound hepatotoxicity & their use should be
rationalized.
13. Factors influencing susceptibility toFactors influencing susceptibility to
hepatotoxicityhepatotoxicity
• Age
• Underlying liver disease (subtle or overt)
• Nutritional status
• Gender
• Ethnic & racial factors
• Pregnancy
• Duration & total dose of drug
• Drug-drug interactions
14. Characterization of hepatotoxicityCharacterization of hepatotoxicity
• Intrinsic hepatotoxicity
§ May occur secondary to metabolic mediated hepatocellular necrosis or
interference with specific hepatocellular pathways.
§ Leads to structural architectural injury thus disruption of excretory
pathways → cholestasis.
§ Almost always dose-dependant
§ Famous e.g. Acetaminophen and alcohol.
• Idiosyncratic hepatotoxicity
§ Unexplained reaction to some drugs
§ Not dose-dependant
§ May be part of an immunologic reaction with other systemic
manifestations.
§ Usually develop after a sensitization period of several weeks.
§ E.g. Isonizid, Valproate, phenytoin and sulphonamides.
15. Drug Induced HepatotoxicityDrug Induced Hepatotoxicity
PathophysiologicPathophysiologic mechanismsmechanisms
• Disruption of the hepatocyte
§ Covalent binding of the drug to intracellular proteins can cause a
decrease in ATP levels, leading to actin disruption. Disassembly of actin
fibrils at the surface of the hepatocyte causes blebs and rupture of the
membrane.
• Disruption of the transport proteins
§ Drugs that affect transport proteins at the canalicular membrane can
interrupt bile flow. Loss of villous processes and interruption of
transport pumps such as multidrug resistance–associated protein 3
prevent the excretion of bilirubin, causing cholestasis.
• Cytolytic T-cell activation
§ Covalent binding of a drug to the P-450 enzyme acts as an immunogen,
activating T cells and cytokines and stimulating a multifaceted immune
response.
16. Drug Induced HepatotoxicityDrug Induced Hepatotoxicity
PathophysiologicPathophysiologic mechanismsmechanisms
• Apoptosis of hepatocytes
§ Activation of the apoptotic pathways by the tumor necrosis factor-alpha
receptor of Fas may trigger the cascade of intercellular caspases, which
results in programmed cell death.
• Mitochondrial disruption
§ Certain drugs inhibit mitochondrial function by a dual effect on both
beta-oxidation energy production by inhibiting the synthesis of
nicotinamide adenine dinucleotide and flavin adenine dinucleotide,
resulting in decreased ATP production.
• Bile duct injury
§ Toxic metabolites excreted in bile may cause injury to the bile duct
epithelium
17. Drug Induced HepatotoxicityDrug Induced Hepatotoxicity
ClinicopathologicalClinicopathological patternspatterns
• Hepatocellular (necroinflammatory) → ALT/AST
§ Inflammation (hepatitis – acute, chronic or fulminant)
§ Steatosis or steatohepatitis
§ Granulomatous à ALP
• Cholestatic → BIL/ALP/ GGT/ERCP
§ PBS
§ Sclerosing cholangitis
• Mixed (hepatocellular & cholestatic) → All LFTs
§ Autoimmune hepatitis
• Vascular (e.g. VOD & Budd-chiari) → Imaging
• Neoplastic (Hepatoma, FNH, etc.)→ Imaging/ a fetoprt.
20. Drugs used in DermatologyDrugs used in Dermatology
• Antifungal drugs
• Antibacterial drugs
• Antiviral drugs
• Corticosteroids
• Drugs affecting skin differentiation and proliferation
• Immunosuppressive and immunomodulatory agents
• Anti-inflammatory drugs
• Paracetamol
• Antipruritic drugs
• Astringents
• Scabicides and pediculicides
• Ultraviolet blocking agents
21. Antifungal drugsAntifungal drugs
• Benzoic acid with salicylic acid
• Miconazole nitrate
• Selenium sulfide
• Sodium thiosulfate
• Ketoconazole
§ It can cause inconsequential biochemical abnormalities with a
necroinflammatory pattern in as many as 3-10% of patients taking it.
§ It is thought to be due to an idiosyncratic mechanism occurring mainly
in middle aged women.
§ several instances of fulminant hepatitis have been recorded.
• Fluconazole
§ It has been associated with modest aminotransferase elevation.
§ Some reports of fatal hepatic necrosis were reported.
22. Antibacterial drugs
• Methylrosanilinium chloride
• Potassium permanganate
• Neomycin with bacitracin
• Silver sulfadiazine
• Tetracycline
§ Acute direct hepatocellular toxicity.
• Penicillin and Amoxicillin-Clavulanic acid
§ Necroinflammatory > cholestatic (mixed).
• Erythromycin
§ Cholestatic Jaundice> ↑ALP and bilirubin.
• Trimethoprim-Sulfamethoxazole
§ Cholestatic (may last for months).
23. Antiviral AgentsAntiviral Agents
• Zidovudine
§ Sporadic cases of biochemical hepatitis.
• Didanosine
§ Elevated transaminases, especially in high doses.
• Interferon alpha
§ It may provoke deterioration of hepatic enzymes when used
for treatment in patients with autoimmune hepatitis.
24. Corticosteroids
• Betamethasone
• Hydrocortisone acetate
§ Flare of viral hepatitis if present à Necroinflammatory.
§ Macrovesicular steatosis.
• Anabolic and Androgenic steroids:
§ Hepatoma.
§ Peliosis Hepatis.
25. Drugs affecting skin differentiation
and proliferation
• Fluorouracil
§ Cream, fluorouracil 5%
§ Rare hepatotoxicity.
• Salicylic acid
§ Topical solution (Cutaneous solution), salicylic acid 5%
§ Ointment , salicylic acid 1–6% [not included on WHO Model
List]
§ Hepatotoxicity is dose dependent à topical salicylates are not
potential hepatotoxic substances.
26. ImmunomodulatorsImmunomodulators
• Cyclosporine
§ powerful immunosuppressive drug with no appreciable effect on the
bone marrow
§ Mechanism of action:
• T-cell dependent and T-cell independent effects.
• It basically modulates immune cell function by inhibiting calcineurin-
dependent dephosphorylation-activation of specific nuclear factors, thus
preventing transcription of pro-inflammatory cytokines.
• In stimulated T cells, this drug inhibits activation by suppressing IL-2
production and IL-2R expression.
• Cyclosporine also inhibits chemokine production by human mast cells,
antigen presentation by Langerhans cells and neutrophil chemotaxis.
§ Infrequent hepatotoxicity.
§ Usually cholestasis with prominent hyperbilirubinemia.
§ Mediated by inhibition of canalicular bile acid transport.
27. ImmunomodulatorsImmunomodulators
• Mycophenolate mofetil (MMF) Celesept
§ Mechanism of action:
• Selectively inhibits inosine monophosphate dehydrogenase
(IMPDH).
• It also induces apoptosis of activated T cells, decreases the
recruitment of lymphocytes and induces immune tolerance.
§ Drug interaction:
• Because of its high affinity for plasma albumin, MPA competes with
other drugs such as salicylates and furosemide that are bound to
albumin; concurrent administration may lead to an accelerated
elimination.
• As MMF and azathioprine block purine synthesis by inhibiting the
same enzyme (IMPDH), MMF should not be used in combination
with azathioprine
§ MMF may prove to be beneficial especially for patients who
are not suited to other systemic immunotherapies because of
hypertension, impaired renal function or liver disease.
28. ImmunomodulatorsImmunomodulators
• Leflunomide
§ antiviral, antitumorigenic, and immunosuppressive
properties.
§ It inhibits autoimmune T-cell proliferation and production
of autoantibodies by B-cells.
§ Dosage:
• Because of the long half-life of its active metabolites,
treatment is initiated at a dose of 100 mg once daily for 3
days and continued with 10-25 mg daily.
§ Adverse effects:
• Gastrointestinal symptoms are the most common
adverse effects.
29. ImmunomodulatorsImmunomodulators
• Tacrolimus
§ Mechanism of action:
• Active against helper T cells, preventing the production of IL-2 via
calcineurin inhibition (binds to tacrolimus-binding protein instead of
cyclophilin protein).
§ Adverse effects:
• Adverse effects include nephrotoxicity, neurotoxicity, glucose
intolerance, and QT prolongation (rare).
• Tacrolimus causes fewer cosmetic effects than cyclosporine, but it
can cause reversible alopecia.
§ Drug-drug interaction:
• Multiple drug interactions are possible, primarily with agents
affecting the cytochrome P-450 system.
30. Immunosuppressive AgentsImmunosuppressive Agents
• Methotrexate
§ Psoriasis à hepatic steatosis, fibrosis and cirrhosis are “not
uncommon”
§ Cumulative dose increases risk.
§ Total dose of 1.5 g is associated with significant liver
disease.
31. Immunosuppressive AgentsImmunosuppressive Agents
• Azathioprine
§ Wide range of hepatotoxic reactions including nodular
regenerative hyperplasia, veno-occlusive disease, and most
commonly cholestasis.
§ Usual asymptomatic aminotransferases elevation.
§ Presumed mechanism of action of hepatotoxicity is via
damage of endothelial cells within terminal hepatic venules
and sinusoids.
32. AntiAnti--inflammatory Drugsinflammatory Drugs
• Overall, extremely low incidence of NSAID-induced
hepatotoxicity BUT extremely common use increases risk.
• Diclofenac (Voltaren)
§ Mixed hepatocellular/cholestatic picture.
§ More in elderly women.
• Sulindac (Clinoril)
§ 50% à cholestatic pattern.
§ More in elderly women.
• Piroxicam (Feldene)
§ Less frequently encountered hepatotoxicity.
33. ParacetamolParacetamol
• Acetaminophen
§ Fulminant hepatic failure in up to 30%.
§ Overdose is the most common cause of drug induced
hepatotoxicity
• Amount ingested as a single dose require to produce
hepatic injury may be 10-20 g.
• Alcoholism is a significant risk factor (therapeutic dose
can cause hepatotoxicity)
§ Prognosis of fulminant hepatitis in such case is poor
§ Liver transplantation is almost always needed
34. Zoom out
Drug induced hepatotoxicityDrug induced hepatotoxicity
DiagnosisDiagnosis
&&
TreatmentTreatment
35. DrugDrug--Induced HepatotoxicityInduced Hepatotoxicity
DiagnosisDiagnosis
• Single agent vs. multiple agents
• History including dose, route of administration, duration, previous
administration, and use of any concomitant drugs, including OTC
medications and herbs ingested in the past 3 months is essential.
§ Onset: The onset is usually within 5-90 days of starting the drug.
§ Exclusion of other causes of liver injury/cholestasisis essential.
• Dechallenge test
• Rechallenge test
36. DrugDrug--Induced HepatotoxicityInduced Hepatotoxicity
DiagnosisDiagnosis
• Lab. tests to assess and diagnose the effects of the suspected medication is
essential.
• Hepatocellular process generally have a disproportionate elevation in serum
aminotransferase levels compared with alkaline phosphatase levels, while
those with cholestasis have the opposite findings.
• The presence of antibodies to specific forms of CYP
• Lymphocyte transformation to test drugs may be observed for drugs acting
through immunologic reactions, but this is not commonly used.
37. DrugDrug--Induced HepatotoxicityInduced Hepatotoxicity
DiagnosisDiagnosis
• Hepatic function tests and their interpretations
§ Bilirubin (total) - To diagnose jaundice and assess severity
§ Bilirubin (unconjugated) - To assess for hemolysis
§ Alkaline phosphatase - To diagnose cholestasis and infiltrative disease
§ AST/serum glutamic oxaloacetic transaminase (SGOT) - To diagnose
hepatocellular disease and assess progression of disease
§ ALT/serum glutamate pyruvate transaminase (SGPT) – more specific for acute
hepatocellular injury
§ Albumin - To assess severity of liver injury
§ Gamma globulin - Large elevations suggestive of autoimmune hepatitis, other
typical increase observed in persons with cirrhosis
§ Prothrombin time after vitamin K - To assess severity of liver disease
§ Antimitochondrial antibody - To diagnose primary biliary cirrhosis
§ ASMA - To diagnose primary sclerosing cholangitis
38. DrugDrug--Induced HepatotoxicityInduced Hepatotoxicity
DiagnosisDiagnosis
• Imaging studies
§ Ultrasonography: inexpensive compared with CT scanning
and MRI and not time consuming.
§ CT scanning
§ MRI
• Liver biopsy
§ Histopathologic evaluation remains an important tool in
diagnosis. A liver biopsy is not essential in every case, but a
morphologic pattern consistent with the expected pattern
provides supportive evidence.
39. Drug Induced HepatotoxicityDrug Induced Hepatotoxicity
TreatmentTreatment
• Early recognition of drug-induced liver reactions
• For drugs that produce liver injury unpredictably, biochemical monitoring
is less useful.
• ALT values are more specific than AST values.
• ALT values that are within the reference range at baseline and rise 2- to 3-
fold should lead to enhanced vigilance in terms of more frequent
monitoring.
• ALT values 4-5 times higher than the reference range should lead to prompt
discontinuation of the drug.
40. Drug Induced HepatotoxicityDrug Induced Hepatotoxicity
TreatmentTreatment
• No specific treatment. Largely supportive and symptomatic.
• First step is to discontinue the suspected drug.
• N-acetylcysteine in the early phases of acetaminophen toxicity.
• L-carnitine is potentially valuable in cases of valproate toxicity.
• In general, corticosteroids have no definitive role in treatment.
• Management of drug-induced cholestasis similar to PBC.
• Cholestyramine may be used for alleviation of pruritus.
• Ursodeoxycholic acid may be used.
• Lastly, consulting a hepatologist can be helpful.
41. Take home messageTake home message
• Egyptian livers are particularly vulnerable
§ LFT’s/Viral markers may be recommended prior to treatment
§ History of liver disease is very important
• Monitor level in blood whenever possible
• Early suspicion & recognition is crucial
• Dechallenge test is helpful
• Target all LFT’s and US if in doubt of specific tests
• Liver supportive measures should be started early
• Hepatology consultation is “round the corner”